Recursion prices $200M stock offering at $3.25 per share

Go back to Recursion prices $200M stock offering at $3.25 per share

Recursion Announces Pricing of $200 Million Underwritten Offering of Class A Common Stock

October 15, 2026 8:30 AM EDT

Salt Lake City, UT, Oct. 15, 2026 (GLOBE NEWSWIRE) -- Recursion Pharmaceuticals, Inc. (Recursion) (NASDAQ: RXRX), a leading clinical-stage company pioneering AI-enabled drug discovery and development decoding biology to radically improve lives, today announced the pricing of an underwritten offering of 61,540,000 shares of its Class A common stock at a price... More